All (n = 229) | GNRI ≥ 92 (n = 198) | GNRI < 92 (n = 31) | p value | |
---|---|---|---|---|
Age (year) | 72.0 ± 8.1 | 76.1 ± 8.4 | 73.5 ± 8.1 | 0.7701) |
Sex, female | 198 (86.5) | 168 (84.8) | 30 (96.8) | 0.1942) |
Fracture type | 0.9032) | |||
AO type A | 13 (5.6) | 11 (5.5) | 2 (6.5) | |
Type B | 82 (35.8) | 70 (35.4) | 12 (38.7) | |
Type C | 134 (58.5) | 117 (59.1) | 17 (54.8) | |
BMI (kg/m2) | 21.9 ± 3.9 | 22.8 ± 3.7 | 18.6 ± 2.6 | < 0.0011) |
Serum albumin (g/dl) | 4.08 ± 0.38 | 4.18 ± 0.28 | 3.47 ± 0.37 | < 0.0011) |
BMD (g/cm2) | 0.881 ± 0.143 | 0.885 ± 0.144 | 0.860 ± 0.136 | 0.3641) |
CCI | 1 (0–2) | 1 (0–2) | 1 (0–2) | 0.0062) |
Total number of drugs administered on admission | 4 (0–14) | 4(0–8) | 5 (0–14) | 0.2741) |
Use of drugs for osteoporosis, n (%) | 36 (15.7) | 32 (16.2) | 4 (12.9) | 0.7942) |
Days between onset and operation | 4.81 ± 1.6 | 4.42 ± 2.1 | 5.18 ± 2.1 | 0.6551) |
BI score | ||||
Admission | 77.2 ± 7.0 | 78.4 ± 6.3 | 69.8 ± 7.01 | < 0.0011) |
One year after surgery | 86.4 ± 8.9 | 88.2 ± 7.8 | 75.2 ± 7.4 | < 0.0011) |
BI efficacy | 9.2 ± 5.6 | 9.8 ± 5.6 | 5.3 ± 2.9 | < 0.0011) |
Mayo wrist score | ||||
1 year after surgery | 84.2 ± 6.6 | 84.3 ± 6.6 | 83.7 ± 6.8 | 0.6451) |
Fall during follow-up periods, n (%) | 21 (9.2) | 9 (4.5) | 12 (38.7) | < 0.0012) |